News

• 28.11.2024
  Bioretec Ltd: 3,000,000 new shares registered with the trade register
• 27.11.2024
  Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million
• 27.11.2024
  Inside information: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 5 million through a private placement of new shares
• 22.11.2024
  Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market
• 20.11.2024
  The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
• 14.11.2024
  Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage
• 04.10.2024
  Inside information: Bioretec updates its financial targets
• 04.10.2024
  Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
• 20.09.2024
  Bioretec’s Shareholders' Nomination Board appointed